References
- Parkman R, Weinberg KI. Immunological reconstitution following hematopoietic stem cell transplantation. In: Thomas ED, Blume KG, Forman SJ, editors. Hematopoietic cell transplantation. Malden: Blackwell Science, 1999:704–11.
- Storek J, Witherspoon RP. Immunologic reconstitution afterhematopoietic stem cell transplantation. In: Atkinson K, editor. Clinical bone marrow and blood stem cell transplantation. Cambridge: Cambridge University Press, 2000:111–46.
- Storek J, Espino G, Dawson MA et al. Low B cell and mono-cyte counts on day 80 are associated with high infection rates between day 100 and 365 after allogeneic marrow transplantation. Blood 2000;96:3290–3.
- Sheridan JF. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic BMT. Blood 1990; 75:1583–6.
- Aucouturier P, Barra A, Intrator L et al. Long lasting IgGsubclass and antibacterial polysaccharide antibody defi-ciency after allogeneic bone marrow transplantation. Blood 1987;70:779–85.
- Riches PG, Walker SA, Rogers TR, Hobbs JR. Relative defihtciency of serum IgA, IgG2 and IgG4 during reconstitution following BMT: relationship to infection. Bone Marrow Transplant 1986;1(Suppl 1):53.
- Sullivan KM, Storek J, Kopecky KJ et al. A controlled trial oflong-term administration of intravenous immunoglobulin to prevent late infection and chronic GvHD following marrow transplantation: Clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 1996;2:44–53.
- von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P et al.Survival in early breast cancer patients is favorably influ-enced by a natural humoral immune response to polymorphic epithelial mucin. 7 Clin Oncol 2000;18:574–83.
- MacLean GD, Reddish MA, Koganty RR, Longenecker BM.Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine. Pmmunother Emphasis Tumor Immunol 1996;19:59–68.
- White CA, Weaver RL, Grillo-Lopez AJ. Antibody-targeted immunotherapy for treatment of malignancy. Annu Rev Med 2001;52:125–45.
- Storek J, Wells D, Dawson MA et al. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell trans-plantation. Blood 2001;98:489–91.